, NARI
--/--/-- --:--:-- Назад к новостям
Дата: | --/--/-- --:--:-- |
Id события: | E5CZE7S3X |
Тип действия: | ACQUISITION |
Статус действия: | COMPLETED |
Символ покупателя: | |
Целевой символ: | NARI |
Обновлено: | --/--/-- --:--:-- |
Цена покупки за акцию: | 80 |
Цена за акцию в валюте: | USD |
Ссылки на новости: | https://www.globenewswire.com/news-release/2025/02/19/3028783/0/en/Stryker-completes-acquisition-of-Inari-Medical-Inc-providing-entry-into-the-high-growth-peripheral-vascular-segment.html |
Action Notes
Stryker has entered into a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. for $80 per share in cash. Under the terms of the agreement, Stryker will commence a tender offer for all outstanding shares of common stock of Inari for $80 per share in cash. Completion of the tender offer is subject to a minimum tender of at least a majority of then-outstanding Inari common shares, the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and other customary conditions. Following successful completion of the tender offer, Stryker will acquire all remaining shares not tendered in the offer through a second step merger at the same price as in the tender offer. The transaction is anticipated to close by the end of Q1 2025, subject to customary closing conditions. On 01/17, Stryker announced a tender off for the outstanding common shares of Inari, that expires 02/18.